ArticleNeoplasia (New York, N.Y.)

Suppression of tumor recurrence and metastasis by a combination of the PHSCN sequence and the antiangiogenic compound tetrathiomolybdate in prostate carcinoma.

Kenneth L van Golen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.